You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

CLINICAL TRIALS PROFILE FOR NORMODYNE


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for NORMODYNE

Trial ID Title Status Sponsor Phase Start Date Summary
NCT02299414 ↗ Chronic Hypertension and Pregnancy (CHAP) Project Active, not recruiting Arrowhead Regional Medical Center Phase 4 2015-06-01 The purpose of this study is to evaluate whether a blood pressure treatment strategy during pregnancy to achieve targets that are recommended for non-pregnant reproductive-age adults (<140/90 mmHg) compared ACOG- recommended standard during pregnancy (no treatment unless BP is severe) is effective and safe.
NCT02299414 ↗ Chronic Hypertension and Pregnancy (CHAP) Project Active, not recruiting Aurora Health Care Phase 4 2015-06-01 The purpose of this study is to evaluate whether a blood pressure treatment strategy during pregnancy to achieve targets that are recommended for non-pregnant reproductive-age adults (<140/90 mmHg) compared ACOG- recommended standard during pregnancy (no treatment unless BP is severe) is effective and safe.
NCT02299414 ↗ Chronic Hypertension and Pregnancy (CHAP) Project Active, not recruiting Baylor College of Medicine Phase 4 2015-06-01 The purpose of this study is to evaluate whether a blood pressure treatment strategy during pregnancy to achieve targets that are recommended for non-pregnant reproductive-age adults (<140/90 mmHg) compared ACOG- recommended standard during pregnancy (no treatment unless BP is severe) is effective and safe.
NCT02299414 ↗ Chronic Hypertension and Pregnancy (CHAP) Project Active, not recruiting Bayview Medical Center Phase 4 2015-06-01 The purpose of this study is to evaluate whether a blood pressure treatment strategy during pregnancy to achieve targets that are recommended for non-pregnant reproductive-age adults (<140/90 mmHg) compared ACOG- recommended standard during pregnancy (no treatment unless BP is severe) is effective and safe.
NCT02299414 ↗ Chronic Hypertension and Pregnancy (CHAP) Project Active, not recruiting Beaumont Hospital Phase 4 2015-06-01 The purpose of this study is to evaluate whether a blood pressure treatment strategy during pregnancy to achieve targets that are recommended for non-pregnant reproductive-age adults (<140/90 mmHg) compared ACOG- recommended standard during pregnancy (no treatment unless BP is severe) is effective and safe.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for NORMODYNE

Condition Name

Condition Name for NORMODYNE
Intervention Trials
Hypertension 1
Hypertension in Pregnancy 1
Postpartum Preeclampsia 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for NORMODYNE
Intervention Trials
Hypertension 2
Pre-Eclampsia 1
Hypertension, Pregnancy-Induced 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for NORMODYNE

Trials by Country

Trials by Country for NORMODYNE
Location Trials
United States 30
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for NORMODYNE
Location Trials
Colorado 1
California 1
Arkansas 1
Alabama 1
Wisconsin 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for NORMODYNE

Clinical Trial Phase

Clinical Trial Phase for NORMODYNE
Clinical Trial Phase Trials
Phase 4 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for NORMODYNE
Clinical Trial Phase Trials
Active, not recruiting 1
Not yet recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for NORMODYNE

Sponsor Name

Sponsor Name for NORMODYNE
Sponsor Trials
Medical College of Wisconsin 1
University of Tennessee Health Science Center 1
University of Alabama at Birmingham 1
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for NORMODYNE
Sponsor Trials
Other 69
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.